Vaud-based medtech company Abionic launches new tool for faster triage of Covid-19 patients

With the launch of its CE-Mark certified device cSOFA, which assesses the severity of Covid-19 among patients within only five minutes of analyzing a blood sample, Abionic aims to prevent hospital overload by allowing health workers to assign patients to general wards, intensive care units or discharge them from the hospital.

 

Since the outbreak of the Covid-19 pandemic, countries around the globe have seen increasing occupancy rates in hospitals. Patient triage, until now, has relied mostly on patient age, a criterion sometimes criticized for being discriminatory.

The Vaud-based start-up and EPFL spin-off Abionic has launched the cSOFA score (Covid Sequential Organ Failure Assessment), which enables a shift from demographic to medical criteria, taking into account the severity of each case. Within only five minutes, the tool will deliver the results that serve as a base for assigning Covid-19 patients.

The newly launched cSOFA relies on PSP (pancreatic stone protein), a novel biomarker Abionic has already clinically validated and marketed. The tool has already obtained the authorization to sell in Europe (CE mark).

 

Cutting-edge nanotechnology for multiple application devices

 

Founded in 2010 and based at the Biopôle, Abionic is a medtech company commercializing a revolutionary nanofluidic technology, providing healthcare professionals with a fast, simple and universal diagnostic tool. Abionic’s cutting-edge Nanotechnology enhances efficiency and versatility of standard ELISA tests to deliver optimal point of care (POC) treatment options with the ability to reduce the current biological techniques from macroscale to nanoscale in a multi-analyte environment.

Abionic’s In Vitro Diagnostic (IVD) platform provides lab-quality results in 5 minutes from a single drop of blood at the POC enabling personalized diagnostics and the possibility of immediate treatment initiation.

 

HubsGoGlobal is a platform under the PharmaBoardroom brand that focuses on the competitive advantages of the Hub and its value proposition in terms of strategic, operational, financial, talent and lifestyle aspects.

PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.

CONTACT

Greater Geneva Bern area is an initiative of the cantons of
Bern, Fribourg, Vaud, Neuchâtel, Geneva and Valais.

World Trade Center – Av. de Gratta-Paille 2
PO Box 252
1000 Lausanne 22 – Switzerland

CONTACT

Copyright: All rights reserved. No part of this site maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this website, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors.

2021 © PharmaBoardroom